Field study of cyproheptadine/chloroquine synergism in falciparum malaria

Pramipexole exposure and risk of incident gambling disorder in individuals with psychiatric disorders: A nationwide register-based cohort study.

Journal of affective disorders·2026

Mortality, morbidity, and predictors of death among amphetamine-type stimulant users - a longitudinal, nationwide register study.

Addictive behaviors reports·2024

Bacteriology of endotracheal tube biofilms and antibiotic resistance: a systematic review.

The Journal of hospital infection·2024

Nationwide, Multioperator Self-Exclusion and Psychiatric Comorbidity in Patients with Gambling Disorder: A Retrospective Chart Review Study from a Regional Treatment Unit.

Journal of addiction·2023

A nationwide case-control study on cardiovascular and respiratory-related disorders in patients with gambling disorder in Sweden.

Public health·2023

Self-exclusion and breaching of self-exclusion from gambling: a repeated survey study on the development of a nationwide self-exclusion service.

Harm reduction journal·2023

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Lancet (London, England)·2026

Remibrutinib versus teriflunomide in relapsing multiple sclerosis (REMODEL-1 and REMODEL-2): two randomised, phase 3 trials.

Lancet (London, England)·2026

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

Lancet (London, England)·2026

Endometrial ablation plus levonorgestrel-releasing intrauterine system versus endometrial ablation alone in women with heavy menstrual bleeding in The Netherlands (MIRA2): a multicentre, open-label, randomised, controlled, superiority trial.

Lancet (London, England)·2026

Disease-free survival and overall survival after neoadjuvant immunotherapy in mismatch repair-deficient colon cancer in the Netherlands: results of the single-arm, multicentre, phase 2, NICHE-2 trial.

Lancet (London, England)·2026

Dupilumab-Responsive Grover Disease with Concomitant Eczematous Dermatitis: A Case Report and Review of 27 Cases.

Case reports in dermatology·2026

Neuroprotective effects of Entandrophragma cylindricum (Meliaceae) extract against "Odontol''-induced cognitive and depressive disorders: An integrated HPLC, molecular docking and experimental validation.

IBRO neuroscience reports·2026

Neuromedin U receptor 2 agonists suppress cocaine self-administration in male rats.

Research square·2026

Artesunate targets STAT3 to alleviate Hodgkin's lymphoma via JAK-STAT/PD-L1 axis.

Biochemical pharmacology·2026

Macamide B alleviates neuronal pyroptosis in spinal cord injury by activating acid ceramidase to inhibit lysosome membrane permeabilization.

Neural regeneration research·2026

Medication-free remission in early-stage Vogt-Koyanagi-Harada disease treated with systemic corticosteroids and conventional immunomodulatory therapy.

International ophthalmology·2026

Related Experiment Videos

Field study of cyproheptadine/chloroquine synergism in falciparum malaria

Related Concept Videos

Pramipexole exposure and risk of incident gambling disorder in individuals with psychiatric disorders: A nationwide register-based cohort study.

Mortality, morbidity, and predictors of death among amphetamine-type stimulant users - a longitudinal, nationwide register study.

Bacteriology of endotracheal tube biofilms and antibiotic resistance: a systematic review.

Nationwide, Multioperator Self-Exclusion and Psychiatric Comorbidity in Patients with Gambling Disorder: A Retrospective Chart Review Study from a Regional Treatment Unit.

A nationwide case-control study on cardiovascular and respiratory-related disorders in patients with gambling disorder in Sweden.

Self-exclusion and breaching of self-exclusion from gambling: a repeated survey study on the development of a nationwide self-exclusion service.

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Remibrutinib versus teriflunomide in relapsing multiple sclerosis (REMODEL-1 and REMODEL-2): two randomised, phase 3 trials.

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

Endometrial ablation plus levonorgestrel-releasing intrauterine system versus endometrial ablation alone in women with heavy menstrual bleeding in The Netherlands (MIRA2): a multicentre, open-label, randomised, controlled, superiority trial.

Disease-free survival and overall survival after neoadjuvant immunotherapy in mismatch repair-deficient colon cancer in the Netherlands: results of the single-arm, multicentre, phase 2, NICHE-2 trial.

Dupilumab-Responsive Grover Disease with Concomitant Eczematous Dermatitis: A Case Report and Review of 27 Cases.

Neuroprotective effects of Entandrophragma cylindricum (Meliaceae) extract against "Odontol''-induced cognitive and depressive disorders: An integrated HPLC, molecular docking and experimental validation.

Neuromedin U receptor 2 agonists suppress cocaine self-administration in male rats.

Artesunate targets STAT3 to alleviate Hodgkin's lymphoma via JAK-STAT/PD-L1 axis.

Macamide B alleviates neuronal pyroptosis in spinal cord injury by activating acid ceramidase to inhibit lysosome membrane permeabilization.

Medication-free remission in early-stage Vogt-Koyanagi-Harada disease treated with systemic corticosteroids and conventional immunomodulatory therapy.

Related Experiment Videos

Field study of cyproheptadine/chloroquine synergism in falciparum malaria

Related Concept Videos

Related Articles